Dodge tries to convert its muscle car fans from V-8 engine to EV

Dodge tries to convert its muscle car fans from V-8 engine to EV


Tim Kuniskis, CEO of Dodge Brand, Stellantis, introduces the Dodge Charger Daytona SRT Concept all-electric muscle car at its world reveal during Dodge’s Speed Week at M1 Concourse on August 17, 2022 in Pontiac, Michigan.

Bill Pugliano | Getty Images

Since the Dodge Charger was reintroduced in 2006, Dodge has been building a reputation for making muscle cars with big engines and bold and bright paint jobs.

But it plans to discontinue the gas-powered Challenger and Charger and the V-8 hemi engines that power some of the most popular versions.

Dodge’s recently debuted fully electric Dodge Charger Daytona SRT Concept is its attempt to retain the muscle car identity in an era when it’s becoming ever more challenging to sell a gas-guzzling sports car.

In fact, it’s becoming more challenging to sell a car at all. SUVs and trucks are taking over the American vehicle market. RBC Capital estimates that Dodge’s sister brands Jeep and Ram account for 50% of parent company Stellantis’ profits.

Meanwhile the many fans of Dodge’s powerful but fuel-thirsty muscle cars are making peace with the apparent end of an era.

Watch the video to learn more.



Source

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored
Business

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored

In this photo illustration Hantavirus samples are seen in Ankara, Turkiye on May 6, 2026. Arman Onal | Anadolu | Getty Images The U.S. Centers for Disease Control and Prevention said there are no hantavirus cases in the country as of Thursday, as it monitors 41 people for the virus. The agency said the risk […]

Read More
These three artworks could sell for 0 million each next week as May auctions begin
Business

These three artworks could sell for $100 million each next week as May auctions begin

A large-scale Jackson Pollock drip painting titled, “Number 7A, 1948.” Crystal Lau | CNBC A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Nearly $2 billion worth of art will come up […]

Read More
Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data
Business

Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data

A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for Alzheimer’s disease to late-stage testing despite disappointing mid-stage trial data, the company said Thursday. Biogen said its experimental drug that targets tau, a protein associated with the memory-robbing disease, failed to show better responses at higher doses. […]

Read More